The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 4, 2013, Pages 798-806

  Deuring, J Jasper ^a   De Haar, Colin ^a   Kuipers, Ernst J ^a   Peppelenbosch, Maikel P ^a   Van Der Woude, C Janneke ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Inflammatory bowel disease; Intestinal epithelial cell; Intestinal epithelium; Mucosal healing; Mucosal inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; B CELL ACTIVATING FACTOR; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CORTICOSTEROID; DEFENSIN; DNA METHYLTRANSFERASE 3A; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 23 RECEPTOR; JANUS KINASE 2; MESALAZINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; RAC PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CROHN DISEASE; CYTOLOGY; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; ENVIRONMENTAL FACTOR; FOOD INTAKE; GENE LOCUS; GENETIC POLYMORPHISM; GOBLET CELL; HUMAN; IMMUNE RESPONSE; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; INTESTINE FLORA; MACROPHAGE; NONHUMAN; OXIDATION; PEYER PATCH; PHAGOCYTOSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ANIMALS; CELL BIOLOGY; ENVIRONMENT; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; METAGENOME;

EID: 84873422293     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.12.020     Document Type: Review

References (149)

1. G.D. Abrams, H. Schneider, S.B. Formal, and H. Sprinz Cellular renewal and mucosal morphology in experimental enteritis. Infection with salmonella typhimurium in the mouse Laboratory Investigation: A Journal of Technical Methods and Pathology 12 1963 1241 1248
2. M.T. Abreu, E.T. Arnold, L.S. Thomas, R. Gonsky, Y. Zhou, and B. Hu TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells Journal of Biological Chemistry 277 2002 20431 20437
3. S.H. Al-Lahham, M.P. Peppelenbosch, H. Roelofsen, R.J. Vonk, and K. Venema Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms Biochimica Et Biophysica Acta 1801 2010 1175 1183
4. C. Alonso, M. Guilarte, M. Vicario, L. Ramos, Z. Ramadan, and M. Antolin Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation Gastroenterology 135 2008 163 172.e1
5. M.R. Amieva, N.R. Salama, L.S. Tompkins, and S. Falkow Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells Cellular Microbiology 4 2002 677 690
6. V. Andersen, J. Christensen, A. Ernst, B.A. Jacobsen, A. Tjonneland, and H.B. Krarup Polymorphisms in NF-kappaB, PXR, LXR, PPARgamma and risk of inflammatory bowel disease World Journal of Gastroenterology 17 2011 197 206
7. C.A. Anderson, G. Boucher, C.W. Lees, A. Franke, M. D'Amato, and K.D. Taylor Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 Nature Genetics 43 2011 246 252
8. E. Ardite, J. Panes, M. Miranda, A. Salas, J.I. Elizalde, and M. Sans Effects of steroid treatment on activation of nuclear factor kappaB in patients with inflammatory bowel disease British Journal of Pharmacology 124 1998 431 433
9. B. Baan, A.A. Dihal, E. Hoff, C.L. Bos, P.W. Voorneveld, and P.J. Koelink 5-aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer Gut 61 2012 1708 1715
10. J.E. Baars, E.J. Kuipers, M. van Haastert, J.J. Nicolai, A.C. Poen, and C.J. van der Woude Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey Journal of Gastroenterology 2012
11. J.C. Barrett, S. Hansoul, D.L. Nicolae, J.H. Cho, R.H. Duerr, and J.D. Rioux Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease Nature Genetics 40 2008 955 962
12. R. Bibiloni, M. Mangold, K.L. Madsen, R.N. Fedorak, and G.W. Tannock The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients Journal of Medical Microbiology 55 2006 1141 1149
13. M.J. Bijvelds, A.G. Bot, J.C. Escher, and H.R. De Jonge Activation of intestinal Cl-secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator Gastroenterology 137 2009 976 985
14. S.A. Bleuming, M.P. Peppelenbosch, D.J. Roberts, and G.R. van den Brink Homeostasis of the adult colonic epithelium: a role for morphogens Scandinavian Journal of Gastroenterology 39 2004 93 98
15. H. Blokzijl, S. Vander Borght, L.I. Bok, L. Libbrecht, M. Geuken, and F.A. van den Heuvel Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels Inflammatory Bowel Diseases 13 2007 710 720
16. G. Bonizzi, and M. Karin The two NF-kappaB activation pathways and their role in innate and adaptive immunity Trends in Immunology 25 2004 280 288
17. K. Cadwell, J.Y. Liu, S.L. Brown, H. Miyoshi, J. Loh, and J.K. Lennerz A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells Nature 456 2008 259 263
18. K. Cadwell, K.K. Patel, N.S. Maloney, T.C. Liu, A.C. Ng, and C.E. Storer Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine Cell 141 2010 1135 1145
19. M. Campieri, S. Adamo, D. Valpiani, A. D'Arienzo, G. D'Albasio, and M. Pitzalis Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study Alimentary Pharmacology & Therapeutics 17 2003 1471 1480
20. E. Cario, and D.K. Podolsky Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease Infection and Immunity 68 2000 7010 7017
21. J.F. Colombel, P. Rutgeerts, W. Reinisch, D. Esser, Y. Wang, and Y. Lang Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis Gastroenterology 141 2011 1194 1201
22. M. Comalada, and M.P. Peppelenbosch Impaired innate immunity in Crohn's disease Trends in Molecular Medicine 12 2006 397 399
23. U.I.G. Consortium, J.C. Barrett, J.C. Lee, C.W. Lees, N.J. Prescott, and C.A. Anderson Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region Nature Genetics 41 2009 1330 1334
24. D. Corridoni, L. Pastorelli, B. Mattioli, S. Locovei, D. Ishikawa, and K.O. Arseneau Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism PloS One 7 2012 e42067
25. J. Cosnes, F. Carbonnel, L. Beaugerie, Y. Le Quintrec, and J.P. Gendre Effects of cigarette smoking on the long-term course of Crohn's disease Gastroenterology 110 1996 424 431
26. S. Cucchiara, L. Stronati, and M. Aloi Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease Journal of Clinical Gastroenterology 46 Suppl. 2012 S64 S66
27. K.M. D'Auria, G.M. Donato, M.C. Gray, G.L. Kolling, C.A. Warren, and L.M. Cave Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control BMC Systems Biology 6 2012 2
28. F. Dallegri, L. Ottonello, A. Ballestrero, F. Bogliolo, F. Ferrando, and F. Patrone Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis Gut 31 1990 184 186
29. H. Das, V. Groh, C. Kuijl, M. Sugita, C.T. Morita, and T. Spies MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function Immunity 15 2001 83 93
30. C. De Filippo, D. Cavalieri, M. Di Paola, M. Ramazzotti, J.B. Poullet, and S. Massart Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa Proceedings of the National Academy of Sciences of the United States of America 107 2010 14691 14696
31. P. Desreumaux, L. Dubuquoy, S. Nutten, M. Peuchmaur, W. Englaro, and K. Schoonjans Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies The Journal of Experimental Medicine 193 2001 827 838
32. J.J. Deuring, C. de Haar, C.L. Koelewijn, E.J. Kuipers, M.P. Peppelenbosch, and C.J. van der Woude Absence of ABCG2-mediated mucosal detoxification in patients with active inflammatory bowel disease is due to impeded protein folding The Biochemical Journal 441 2012 87 93 (DDW, abstract no. 1291342).
33. J.J. Deuring, M.P. Peppelenbosch, E.J. Kuipers, C.J. van der Woude, and C. de Haar Impeded protein folding and function in active inflammatory bowel disease Biochemical Society Transactions 39 2011 1107 1111
34. Deuring JJ, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ, 2012. Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease, in preparation.
35. -/- mice Nature 487 2012 104 108
36. A. Dignass, G. Van Assche, J.O. Lindsay, M. Lemann, J. Soderholm, and J.F. Colombel The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management Journal of Crohn's & Colitis 4 2010 28 62
37. M.G. Dominguez-Bello, M.J. Blaser, R.E. Ley, and R. Knight Development of the human gastrointestinal microbiota and insights from high-throughput sequencing Gastroenterology 140 2011 1713 1719
38. D.R. Donohoe, N. Garge, X. Zhang, W. Sun, T.M. O'Connell, and M.K. Bunger The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon Cell Metabolism 13 2011 517 526
39. M.M. Dring, C.A. Goulding, V.I. Trimble, D. Keegan, A.W. Ryan, and K.M. Brophy The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease Gastroenterology 130 2006 341 348 quiz 592
40. J.A. Eaden, K.R. Abrams, and J.F. Mayberry The risk of colorectal cancer in ulcerative colitis: a meta-analysis Gut 48 2001 526 535
41. L.J. Egan, D.C. Mays, C.J. Huntoon, M.P. Bell, M.G. Pike, and W.J. Sandborn Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity The Journal of Biological Chemistry 274 1999 26448 26453
42. L. Fajas, D. Auboeuf, E. Raspe, K. Schoonjans, A.M. Lefebvre, and R. Saladin The organization, promoter analysis, and expression of the human PPARgamma gene The Journal of Biological Chemistry 272 1997 18779 18789
43. A. Franke, D.P. McGovern, J.C. Barrett, K. Wang, G.L. Radford-Smith, and T. Ahmad Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci Nature Genetics 42 2010 1118 1125
44. R.M. Gadaleta, B. Oldenburg, E.C. Willemsen, M. Spit, S. Murzilli, and L. Salvatore Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-kappaB signaling in the intestine Biochimica Et Biophysica Acta 2011
45. R.M. Gadaleta, K.J. van Erpecum, B. Oldenburg, E.C. Willemsen, W. Renooij, and S. Murzilli Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease Gut 2011
46. M.N. Goke, M. Schneider, W. Beil, and M.P. Manns Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithelium Regulatory Peptides 105 2002 203 214
47. H.A. Gordon, and L. Pesti The gnotobiotic animal as a tool in the study of host microbial relationships Bacteriological Reviews 35 1971 390 429
48. T. Goretsky, R. Dirisina, P. Sinh, N. Mittal, E. Managlia, and D.B. Williams p53 mediates TNF-induced epithelial cell apoptosis in IBD The American Journal of Pathology 2012
49. V. Groh, S. Bahram, S. Bauer, A. Herman, M. Beauchamp, and T. Spies Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium Proceedings of the National Academy of Sciences of the United States of America 93 1996 12445 12450
50. V. Groh, R. Rhinehart, J. Randolph-Habecker, M.S. Topp, S.R. Riddell, and T. Spies Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells Nature Immunology 2 2001 255 260
51. J. Groot, P. Bijlsma, A. Van Kalkeren, A. Kiliaan, P. Saunders, and M. Perdue Stress-induced decrease of the intestinal barrier function. The role of muscarinic receptor activation Annals of the New York Academy of Sciences 915 2000 237 246
52. M. Hamady, and R. Knight Microbial community profiling for human microbiome projects: tools, techniques, and challenges Genome Research 19 2009 1141 1152
53. S.B. Hanauer, B.G. Feagan, G.R. Lichtenstein, L.F. Mayer, S. Schreiber, and J.F. Colombel Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Lancet 359 2002 1541 1549
54. J.C. Hardwick, M. van Santen, G.R. van den Brink, S.J. van Deventer, and M.P. Peppelenbosch DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1 Carcinogenesis 25 2004 1293 1298
55. A. Hart, and M.A. Kamm Review article: mechanisms of initiation and perpetuation of gut inflammation by stress Alimentary Pharmacology & Therapeutics 16 2002 2017 2028
56. K. Hase, K. Kawano, T. Nochi, G.S. Pontes, S. Fukuda, and M. Ebisawa Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response Nature 462 2009 226 230
57. X. Hebuterne, M. Lemann, Y. Bouhnik, O. Dewit, J.L. Dupas, and M. Mross Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol Gut 2012
58. R.M. Hershberg, D.H. Cho, A. Youakim, M.B. Bradley, J.S. Lee, and P.E. Framson Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells The Journal of Clinical Investigation 102 1998 792 803
59. R.M. Hershberg, P.E. Framson, D.H. Cho, L.Y. Lee, S. Kovats, and J. Beitz Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing The Journal of Clinical Investigation 100 1997 204 215
60. L.M. Higuchi, H. Khalili, A.T. Chan, J.M. Richter, A. Bousvaros, and C.S. Fuchs A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women The American Journal of Gastroenterology 107 2012 1399 1406
61. J.P. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J.P. Cezard, and J. Belaiche Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599 603
62. Y. Isozaki, N. Yoshida, M. Kuroda, O. Handa, T. Takagi, and S. Kokura Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis Scandinavian Journal of Gastroenterology 41 2006 944 953
63. D.P. Jewell, and S.C. Truelove Azathioprine in ulcerative colitis: final report on controlled therapeutic trial British Medical Journal 4 1974 627 630
64. M.E. Johansson, and G.C. Hansson Microbiology keeping bacteria at a distance Science 334 2011 182 183
65. L. Jostins, S. Ripke, R.K. Weersma, R.H. Duerr, D.P. McGovern, and K.Y. Hui Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 2012 119 124
66. M. Karin, and F.R. Greten NF-kappaB: linking inflammation and immunity to cancer development and progression Nature Reviews Immunology 5 2005 749 759
67. A. Kaser, A.H. Lee, A. Franke, J.N. Glickman, S. Zeissig, and H. Tilg XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease Cell 134 2008 743 756
68. J.E. Koenig, A. Spor, N. Scalfone, A.D. Fricker, J. Stombaugh, and R. Knight Succession of microbial consortia in the developing infant gut microbiome Proceedings of the National Academy of Sciences of the United States of America 108 Suppl. 1 2011 4578 4585
69. T. Langmann, C. Moehle, R. Mauerer, M. Scharl, G. Liebisch, and A. Zahn Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes Gastroenterology 127 2004 26 40
70. M.G. Laukoetter, M. Bruewer, and A. Nusrat Regulation of the intestinal epithelial barrier by the apical junctional complex Current Opinion in Gastroenterology 22 2006 85 89
71. G.R. Lichtenstein, and P. Rutgeerts Importance of mucosal healing in ulcerative colitis Inflammatory Bowel Diseases 16 2010 338 346
72. P. Lionetti, M.L. Callegari, S. Ferrari, M.C. Cavicchi, E. Pozzi, and M. de Martino Enteral nutrition and microflora in pediatric Crohn's disease JPEN Journal of Parenteral and Enteral Nutrition 29 2005 S173 S175 (discussion S5-8, S84-88).
73. J.S. Maltzman, and G.A. Koretzky Azathioprine: old drug, new actions The Journal of Clinical Investigation 111 2003 1122 1124
74. C. Manichanh, N. Borruel, F. Casellas, and F. Guarner The gut microbiota in IBD Nature Reviews Gastroenterology & Hepatology 9 2012 599 608
75. G.J. Mantzaris, A. Christidou, M. Sfakianakis, A. Roussos, S. Koilakou, and K. Petraki Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease Inflammatory Bowel Diseases 15 2009 375 382
76. M. Marini, G. Bamias, J. Rivera-Nieves, C.A. Moskaluk, S.B. Hoang, and W.G. Ross TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis Proceedings of the National Academy of Sciences of the United States of America 100 2003 8366 8371
77. J.K. Marshall, and E.J. Irvine Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis Gut 40 1997 775 781
78. G.M. Matthews, G.S. Howarth, and R.N. Butler Short-chain fatty acids induce apoptosis in colon cancer cells associated with changes to intracellular redox state and glucose metabolism Chemotherapy 58 2012 102 109
79. J.R. McDole, L.W. Wheeler, K.G. McDonald, B. Wang, V. Konjufca, and K.A. Knoop Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine Nature 483 2012 345 349
80. L.I. McKay, and J.A. Cidlowski Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways Endocrine Reviews 20 1999 435 459
81. K. Mitsuyama, and M. Sata Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease Expert Opinion on Therapeutic Targets 12 2008 301 312
82. B.D. Muegge, J. Kuczynski, D. Knights, J.C. Clemente, A. Gonzalez, and L. Fontana Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans Science 332 2011 970 974
83. Y. Murakami, T. Matsui, F. Hirai, N. Takatsu, Y. Takaki, and T. Nagahama Efficacy of azathioprine in mild or moderate relapse in Crohn's disease: clinical and endoscopic evaluation Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society 22 2010 25 32
84. A. Nenci, C. Becker, A. Wullaert, R. Gareus, G. van Loo, and S. Danese Epithelial NEMO links innate immunity to chronic intestinal inflammation Nature 446 2007 557 561
85. M.F. Neurath, and S.P. Travis Mucosal healing in inflammatory bowel diseases: a systematic review Gut 61 2012 1619 1635
86. O.H. Nielsen, J.T. Bjerrum, C. Csillag, F.C. Nielsen, and J. Olsen Influence of smoking on colonic gene expression profile in Crohn's disease PloS One 4 2009 e6210
87. R.M. Nijmeijer, R.M. Gadaleta, S.W. van Mil, A.A. van Bodegraven, J.B. Crusius, and G. Dijkstra Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease PLoS One 6 2011 e23745
88. Y. Ogura, D.K. Bonen, N. Inohara, D.L. Nicolae, F.F. Chen, and R. Ramos A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 2001 603 606
89. G. Olaison, R. Sjodahl, and C. Tagesson Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation Gut 31 1990 325 328
90. J.M. Otte, E. Cario, and D.K. Podolsky Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells Gastroenterology 126 2004 1054 1070
91. E.J. Park, I. Takahashi, J. Ikeda, K. Kawahara, T. Okamoto, and M.N. Kweon Clonal expansion of double-positive intraepithelial lymphocytes by MHC class I-related chain A expressed in mouse small intestinal epithelium Journal of Immunology 171 2003 4131 4139
92. L. Pastorelli, R.R. Garg, S.B. Hoang, L. Spina, B. Mattioli, and M. Scarpa Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis Proceedings of the National Academy of Sciences of the United States of America 107 2010 8017 8022
93. B. Patel, R. Schutte, P. Sporns, J. Doyle, L. Jewel, and R.N. Fedorak Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease Inflammatory Bowel Diseases 8 2002 340 346
94. E. Patterson, R. Wall, G.F. Fitzgerald, R.P. Ross, and C. Stanton Health implications of high dietary omega-6 polyunsaturated Fatty acids Journal of Nutrition and Metabolism. 2012 2012 539426
95. V. Payne, and P.C. Kam Mast cell tryptase: a review of its physiology and clinical significance Anaesthesia 59 2004 695 703
96. A. Pellicoro, and K.N. Faber Review article: the function and regulation of proteins involved in bile salt biosynthesis and transport Alimentary Pharmacology and Therapeutics 26 Suppl. 2 2007 149 160
97. G. Perminow, J. Beisner, M. Koslowski, L.G. Lyckander, E. Stange, and M.H. Vatn Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease American Journal of Gastroenterology 105 2010 452 459
98. G. Pineton de Chambrun, L. Peyrin-Biroulet, M. Lemann, and J.F. Colombel Clinical implications of mucosal healing for the management of IBD Nature Reviews Gastroenterology & Hepatology 7 2010 15 29
99. T. Prindiville, M. Cantrell, and K.H. Wilson Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease Inflammatory Bowel Diseases 10 2004 824 833
100. S. Reif, I. Klein, F. Lubin, M. Farbstein, A. Hallak, and T. Gilat Pre-illness dietary factors in inflammatory bowel disease Gut 40 1997 754 760
101. W. Reinisch, W.J. Sandborn, P. Rutgeerts, B.G. Feagan, D. Rachmilewitz, and S.B. Hanauer Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies Inflammatory Bowel Diseases 18 2012 201 211
102. M. Rescigno The pathogenic role of intestinal flora in IBD and colon cancer Current Drug Targets 9 2008 395 403
103. F. Rieder, T. Karrasch, S. Ben-Horin, A. Schirbel, R. Ehehalt, and J. Wehkamp Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing Journal of Crohn's & Colitis 6 2012 373 385
104. L. Rigoli, C. Romano, R.A. Caruso, M.A. Lo Presti, C. Di Bella, and V. Procopio Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease World Journal of Gastroenterology 14 2008 4454 4461
105. T. Ritsema, and S. Smeekens Fructans: beneficial for plants and humans Current Opinion in Plant Biology 6 2003 223 230
106. F. Rizzello, P. Gionchetti, A. D'Arienzo, F. Manguso, G. Di Matteo, and V. Annese Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study Alimentary Pharmacology & Therapeutics 16 2002 1109 1116
107. P. Rutgeerts, W.J. Sandborn, B.G. Feagan, W. Reinisch, A. Olson, and J. Johanns Infliximab for induction and maintenance therapy for ulcerative colitis The New England Journal of Medicine 353 2005 2462 2476
108. P. Rutgeerts, G. Van Assche, W.J. Sandborn, D.C. Wolf, K. Geboes, and J.F. Colombel Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial Gastroenterology 142 2012 1102 1111 e2
109. D.J. Ruthig, and K.A. Meckling-Gill Both (n-3) and (n-6) fatty acids stimulate wound healing in the rat intestinal epithelial cell line, IEC-6 The Journal of Nutrition 129 1999 1791 1798
110. N.H. Salzman, M.A. Underwood, and C.L. Bevins Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa Seminars in Immunology 19 2007 70 83
111. A. Samba-Louaka, J.P. Nougayrede, C. Watrin, E. Oswald, and F. Taieb The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells Infection and Immunity 77 2009 5471 5477
112. G.I. Sandle Salt and water absorption in the human colon: a modern appraisal Gut 43 1998 294 299
113. M. Sandoval, X. Liu, E.E. Mannick, D.A. Clark, and M.J. Miller Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine Gastroenterology 113 1997 1480 1488
114. J. Santos, P.C. Yang, J.D. Soderholm, M. Benjamin, and M.H. Perdue Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat Gut 48 2001 630 636
115. R.B. Sartor Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics Gastroenterology 126 2004 1620 1633
116. T. Sato, J.H. van Es, H.J. Snippert, D.E. Stange, R.G. Vries, and M. van den Born Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts Nature 2010
117. S. Schreiber, S. Nikolaus, and J. Hampe Activation of nuclear factor kappa B inflammatory bowel disease Gut 42 1998 477 484
118. R. Sen, and D. Baltimore Multiple nuclear factors interact with the immunoglobulin enhancer sequences Cell 46 1986 705 716
119. U. Senftleben, Y. Cao, G. Xiao, F.R. Greten, G. Krahn, and G. Bonizzi Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway Science 293 2001 1495 1499
120. Y.M. Shah, X. Ma, K. Morimura, I. Kim, and F.J. Gonzalez Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression American Journal of Physiology. Gastrointestinal and Liver Physiology 292 2007 G1114 G1122
121. F. Shanahan The colonic microflora and probiotic therapy in health and disease Current Opinion in Gastroenterology 27 2011 61 65
122. O. Shibolet, and D.K. Podolsky TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction American Journal of Physiology. Gastrointestinal and Liver Physiology 292 2007 G1469 G1473
123. M. Sidoroff, and K.L. Kolho Glucocorticoid sensitivity in inflammatory bowel disease Annals of Medicine 44 2011 578 587
124. A.P. Simopoulos Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 60 2006 502 507
125. A. Sonnenberg Geographic and temporal variations of sugar and margarine consumption in relation to Crohn's disease Digestion 41 1988 161 171
126. M. Stanislawowski, P.M. Wierzbicki, A. Golab, K. Adrych, D. Kartanowicz, and J. Wypych Decreased toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients Journal of Physiology and Pharmacology 60 Suppl. 4 2009 71 75
127. S. Sullivan, P. Alex, T. Dassopoulos, N.C. Zachos, C. Iacobuzio-Donahue, and M. Donowitz Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea Inflammatory Bowel Diseases 15 2009 261 274
128. L. Sun, G.M. Nava, and T.S. Stappenbeck Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease Current Opinion in Gastroenterology 27 2011 321 327
129. J. Taipalensuu, H. Tornblom, G. Lindberg, C. Einarsson, F. Sjoqvist, and H. Melhus Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers The Journal of Pharmacology and Experimental Therapeutics 299 2001 164 170
130. E. Thachil, J.P. Hugot, B. Arbeille, R. Paris, A. Grodet, and M. Peuchmaur Abnormal activation of autophagy-induced crinophagy in paneth cells from patients with Crohn's disease Gastroenterology 142 2012 1097 1099
131. G.R. Thompson, and P.C. Trexler Gastrointestinal structure and function in germ-free or gnotobiotic animals Gut 12 1971 230 235
132. I. Tiede, G. Fritz, S. Strand, D. Poppe, R. Dvorsky, and D. Strand CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes The Journal of Clinical Investigation 111 2003 1133 1145
133. M.P. Tighe, J.R. Cummings, and N.A. Afzal Nutrition and inflammatory bowel disease: primary or adjuvant therapy Current Opinion in Clinical Nutrition and Metabolic Care 14 2011 491 496
134. L.H. Travassos, L.A. Carneiro, M. Ramjeet, S. Hussey, Y.G. Kim, and J.G. Magalhaes Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry Nature Immunology 11 2010 55 62
135. S.P. Travis, E.F. Stange, M. Lemann, T. Oresland, W.A. Bemelman, and Y. Chowers European evidence-based Consensus on the management of ulcerative colitis: current management Journal of Crohn's & Colitis 2 2008 24 62
136. N. Turjman, and P.P. Nair Nature of tissue-bound lithocholic acid and its implications in the role of bile acids in carcinogenesis Cancer Research 41 1981 3761 3763
137. J.R. Turner Intestinal mucosal barrier function in health and disease Nature Reviews Immunology 9 2009 799 809
138. B.L. Urquhart, R.G. Tirona, and R.B. Kim Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs Journal of Clinical Pharmacology 47 2007 566 578
139. B.L. Urquhart, J.A. Ware, R.G. Tirona, R.H. Ho, B.F. Leake, and U.I. Schwarz Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe Physiological Genomics 18 2008 439 448
140. A.S. Vamadevan, M. Fukata, E.T. Arnold, L.S. Thomas, D. Hsu, and M.T. Abreu Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis Innate Immunity 16 2009 93 103
141. F. van der Heide, M. Wassenaar, K. van der Linde, P. Spoelstra, J.H. Kleibeuker, and G. Dijkstra Effects of active and passive smoking on Crohn's disease and ulcerative colitis in a cohort from a regional hospital European Journal of Gastroenterology & Hepatology 23 2011 255 261
142. E.P. van der Zanden, S.A. Snoek, S.E. Heinsbroek, O.I. Stanisor, C. Verseijden, and G.E. Boeckxstaens Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic acetylcholine receptor alpha4beta2 Gastroenterology 137 2009 1029 1039 1039.e1-4
143. M.W. van Passel, R. Kant, E.G. Zoetendal, C.M. Plugge, M. Derrien, and S.A. Malfatti The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes PloS One 6 2011 e16876
144. K. Vandenbroucke, W. Hans, J. Van Huysse, S. Neirynck, P. Demetter, and E. Remaut Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice Gastroenterology 127 2004 502 513
145. P. Vora, A. Youdim, L.S. Thomas, M. Fukata, S.Y. Tesfay, and K. Lukasek Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells Journal of Immunology 173 2004 5398 5405
146. T.M. Willson, and S.A.P.X.R. Kliewer CAR and drug metabolism Nature Reviews Drug Discovery 1 2002 259 266
147. C. Xu, C.Y. Li, and A.N. Kong Induction of phase I, II and III drug metabolism/transport by xenobiotics Archives of Pharmacal Research 28 2005 249 268
148. S. Yuvaraj, M.P. Peppelenbosch, and N.A. Bos Transgenic probiotica as drug delivery systems: the golden bullet Expert Opinion on Drug Delivery 4 2007 1 3
149. C. Zhou, M.M. Tabb, E.L. Nelson, F. Grun, S. Verma, and A. Sadatrafiei Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation Journal of Clinical Investigation 116 2006 2280 2289